BARTELS TOXOPLASMA IGM EIA— 510(k) K922579

Name: FDA 510(k) clearance K922579
Creator: U.S. Food and Drug Administration
Published: 1992-09-02

Substantially Equivalent

Baxter Diagnostics, Inc.

FDA 510(k) clearance K922579 for BARTELS TOXOPLASMA IGM EIA, Substantially Equivalent on 1992-09-02. Applicant: Baxter Diagnostics, Inc.. Device class: 2.

Clearance details

Applicant: Baxter Diagnostics, Inc.
Product code: Code LGD
Device class: Class 2
Regulation: 21 CFR 866.3780
Advisory panel: Microbiology
Date received: 1992-05-27
Decision date: 1992-09-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bellevue, WA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LGD

view all

K242022 — Access Toxo IgG2025-03-28
K242095 — Access Toxo IgM II2024-10-11
K233932 — Alinity i Toxo IgM2024-08-30
K210596 — ARCHITECT Toxo IgG2022-05-19
K162678 — Elecsys Toxo IgM, Elecsys Toxo IgM PreciControl2017-06-23

More clearances from Baxter Diagnostics, Inc.

view all

K934458 — DRIED GRAM-POSITIVE MIC/COMBO PANELS1995-07-18
K950817 — DRIED GRAM POSITIVE MIC/COMBO PANELS/PNEUMOCOCCI1995-04-25
K935704 — DRIED GRAM-NEGATIVE MIC//COMBO PANELS1995-04-14
K950570 — STRATUS PROGESTERONE FLUOROMETRIC ENZYME IMMUNOASSAY1995-04-11
K945235 — DRIED GRAM-POSITIVE MIC/COMBO PANELS1995-03-07

Adverse events under product code LGD

product code LGD

Malfunction: 502
Total: 502

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.